These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. A multiple dose comparative study of the pharmacodynamic and pharmacokinetic behaviour of polymer-matrix and Oros dosage forms of oxprenolol in healthy volunteers. Woods KL; Jack DB; Kendall MJ; Halsey A; O'Donnell ML; Warrington SJ; John VA Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):177S-184S. PubMed ID: 4005120 [TBL] [Abstract][Full Text] [Related]
9. Absorption and excretion of rapid and slow release oxprenolol and their effects on heart rate and blood pressure during exercise. Bobik A; Jennings GL; Korner PI; Ashley P; Jackman G Br J Clin Pharmacol; 1979 Jun; 7(6):545-9. PubMed ID: 465276 [TBL] [Abstract][Full Text] [Related]
10. Effect of slow oxprenolol and a combination of slow oxprenolol and cyclopenthiazide on plasma lipoproteins. Ballantyne D; Ballantyne FC; McMurdo Atherosclerosis; 1981 Jun; 39(3):301-6. PubMed ID: 7259814 [TBL] [Abstract][Full Text] [Related]
11. Influence of intrinsic sympathomimetic activity and cardioselectivity on beta adrenoceptor blockade. McDevitt DG; Brown HC; Carruthers SG; Shanks RG Clin Pharmacol Ther; 1977 May; 21(5):556-66. PubMed ID: 15753 [TBL] [Abstract][Full Text] [Related]
12. A comparison of slow Trasicor (oxprenolol 160 mg) and Trasidrex (oxprenolol 160 mg and cyclopenthiazide 0.25 mg) in the treatment of hypertension in general practice. Elsdon-Dew RW; Holden E J Int Med Res; 1981; 9(5):315-8. PubMed ID: 7028531 [No Abstract] [Full Text] [Related]
13. Pharmacokinetics of oxprenolol in normal subjects. Mason WD; Winer N Clin Pharmacol Ther; 1976 Oct; 20(4):401-12. PubMed ID: 10124 [TBL] [Abstract][Full Text] [Related]
14. Slow release oxprenolol in angina pectoris: study comparing oxprenolol, once daily, with propranolol, four times daily. Olowoyeye JO; Thadani U; Parker JO Am J Cardiol; 1981 May; 47(5):1123-7. PubMed ID: 7223659 [TBL] [Abstract][Full Text] [Related]
15. Twenty-four hour effects of oxprenolol Oros and atenolol on heart rate, blood pressure, exercise tolerance and perceived exertion. van Baak MA; Verstappen FT; Oosterhuis B Eur J Clin Pharmacol; 1986; 30(4):399-406. PubMed ID: 3743615 [TBL] [Abstract][Full Text] [Related]
16. Oxprenolol slow-release with cyclopenthiazide KCl in the treatment of essential hypertension. A multicentre general practice study. Levenstein JH S Afr Med J; 1981 Jun; 59(25):893-9. PubMed ID: 7015537 [TBL] [Abstract][Full Text] [Related]
17. Beta adrenergic blockade and diuretic therapy in benign essential hypertension: A dynamic assessment. Davies R; Payne NN; Slater JD Am J Cardiol; 1976 Mar; 37(4):637-41. PubMed ID: 3963 [TBL] [Abstract][Full Text] [Related]
18. Observations on some properties of a long-acting preparation of propranolol. Shanks RG; Neill JD; Leahey WJ; Varma MP Clin Sci (Lond); 1979 Dec; 57 Suppl 5():409s-411s. PubMed ID: 540460 [TBL] [Abstract][Full Text] [Related]
19. Exercise and resting blood pressure and heart rate changes 24 h after dosing in patients with essential hypertension receiving 16/260 oxprenolol Oros once daily. Müller FB; Allsopp LF; Cooper GL; Bolli P; Frei P; Glaus L; Ritz R; Bühler FR Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):207S-212S. PubMed ID: 4005124 [TBL] [Abstract][Full Text] [Related]
20. Effects of different preparations of oxprenolol on diurnal variations of non-steady-state exercise performance in patients with coronary heart disease evaluated by computer assisted ergospirometry. Reiterer W Arzneimittelforschung; 1980; 30(7):1147-53. PubMed ID: 7191298 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]